REGENERON PHARMACEUTICALS, INC.·4

Jun 12, 4:10 PM ET

LAROSA JOSEPH J 4

4 · REGENERON PHARMACEUTICALS, INC. · Filed Jun 12, 2024

Insider Transaction Report

Form 4
Period: 2024-06-10
LAROSA JOSEPH J
SVP Gen Counsel and Secretary
Transactions
  • Gift

    Common Stock

    2024-06-101,6080 total(indirect: 2022 GRAT)
Holdings
  • Common Stock

    36,437
  • Common Stock

    (indirect: By 401(k))
    371

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT